Sunil R. Hingorani, MD, PhD
Fred Hutchinson Cancer Research Center
Sunil R. Hingorani is a medical oncologist and cancer biologist specializing in pancreas cancer.
He is a member with joint appointments in the Clinical Research and Public Health Sciences Divisions at Fred Hutchinson Cancer Research Center, and associate professor in the Department of Medicine, Division of Medical Oncology at University of Washington (UW) School of Medicine. He received a Bachelor of Science degree in molecular biophysics and biochemistry from Yale College and a doctorate in cellular and molecular physiology and a medical degree from Yale University. He completed a fellowship in hematology and oncology at Dana-Farber Cancer Institute in Boston and performed postdoctoral research at MIT.
Dr. Hingorani is the founding director of the Pancreas Cancer Specialty Clinic at the Seattle Cancer Care Alliance (SCCA), a real-time multidisciplinary clinic which serves as the focal point for a comprehensive translational research program in pancreas cancer, the Center for Accelerated Translation in Pancreas Cancer (CATPAC), which he also directs. His laboratory studies the molecular and cellular pathogenesis of pancreas cancer primarily through the use of genetically engineered mouse models. These animal models of distinct genetic subtypes of pancreas cancer form the basis for an integrated, systematic, and multidisciplinary program of study. Dr. Hingorani is principal investigator of a national phase 2 trial testing the strategy of enzymatic degradation of hyaluronan in combination with standard chemotherapy for metastatic pancreas cancer.